Decreased miR-132 and increased Bmi-1 expression were more common in CC patients with locally advanced disease (stages IIa and IIIa), those with low- and moderately- differentiated tumors, and those with larger maximum focus tumor diameters (≥ 4 cm) (all P < 0.05). This evidence concerns the gene BMI1 and neoplasm.